Optimum Use of Acute Treatments for Hereditary Angioedema: Evidence-Based Expert Consensus

por Longhurst, Hilary
Publicado 2018

Management of acute attacks of hereditary angioedema: potential role of icatibant

por Longhurst, Hilary J
Publicado 2010

A Review of Randomized Controlled Trials of Hereditary Angioedema Long-Term Prophylaxis with C1 Inhibitor Replacement Therapy: Alleviation of Disease Symptoms Is Achievable

por Longhurst, Hilary J, Valerieva, Anna
Publicado 2023

Treatment of hereditary angioedema—single or multiple pathways to the rescue

por Valerieva, Anna, Longhurst, Hilary J.
Publicado 2022

Mitigating Disparity in Health-care Resources Between Countries for Management of Hereditary Angioedema

por Jindal, Ankur Kumar, Reshef, Avner, Longhurst, Hilary
Publicado 2021

Editorial: C1 inhibitor deficiency and angioedema

por Farkas, Henriette, Germenis, Anastasios E., Longhurst, Hilary
Publicado 2022

Hereditary angioedema with C1 inhibitor deficiency: delay in diagnosis in Europe

por Zanichelli, Andrea, Magerl, Markus, Longhurst, Hilary, Fabien, Vincent, Maurer, Marcus
Publicado 2013

The Role of Herpes Viruses in Pulmonary Fibrosis

por Duckworth, Anna, Longhurst, Hilary J., Paxton, Jane K., Scotton, Chris J.
Publicado 2021

Primary vs. Secondary Antibody Deficiency: Clinical Features and Infection Outcomes of Immunoglobulin Replacement

por Duraisingham, Sai S., Buckland, Matthew, Dempster, John, Lorenzo, Lorena, Grigoriadou, Sofia, Longhurst, Hilary J.
Publicado 2014

Are All Primary Immunodeficiency Disorders Inborn Errors of Immunity?

por Ameratunga, Rohan, Longhurst, Hilary, Lehnert, Klaus, Steele, Richard, Edwards, Emily S. J., Woon, See-Tarn
Publicado 2021

The Icatibant Outcome Survey: treatment of laryngeal angioedema attacks

por Longhurst, Hilary J., Aberer, Werner, Bouillet, Laurence, Caballero, Teresa, Maurer, Marcus, Fabien, Vincent, Zanichelli, Andrea
Publicado 2016

Effectiveness of icatibant for treatment of hereditary angioedema attacks is not affected by body weight: findings from the Icatibant Outcome Survey, a cohort observational study

por Caballero, Teresa, Zanichelli, Andrea, Aberer, Werner, Maurer, Marcus, Longhurst, Hilary J., Bouillet, Laurence, Andresen, Irmgard
Publicado 2018

Correction to: Mitigating Disparity in Healthcare Resources Between Countries for Management of Hereditary Angioedema

por Jindal, Ankur Kumar, Reshef, Avner, Longhurst, Hilary, Management), GEHM workgroup (Global Equity in H. A. E.
Publicado 2021

SARS-CoV-2 Omicron: Light at the End of the Long Pandemic Tunnel or Another False Dawn for Immunodeficient Patients?

por Ameratunga, Rohan, Leung, Euphemia, Woon, See-Tarn, Chan, Lydia, Steele, Richard, Lehnert, Klaus, Longhurst, Hilary
Publicado 2022

Common Variable Immunodeficiency Disorders, T-Cell Responses to SARS-CoV-2 Vaccines, and the Risk of Chronic COVID-19

por Ameratunga, Rohan, Longhurst, Hilary, Steele, Richard, Lehnert, Klaus, Leung, Euphemia, Brooks, Anna E.S., Woon, See-Tarn
Publicado 2021

New Frontiers in Subcutaneous Immunoglobulin Treatment

por Jolles, Stephen, Stein, Mark R., Longhurst, Hilary J., Borte, Michael, Ritchie, Bruce, Sturzenegger, Matthias H., Berger, Melvin
Publicado 2011

Development and content validity testing of a patient-reported outcomes questionnaire for the assessment of hereditary angioedema in observational studies

por Bonner, Nicola, Abetz-Webb, Linda, Renault, Lydie, Caballero, Teresa, Longhurst, Hilary, Maurer, Marcus, Christiansen, Sandra, Zuraw, Bruce
Publicado 2015

Breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis are responsive to icatibant: findings from the Icatibant Outcome Survey

por Aberer, Werner, Maurer, Marcus, Bouillet, Laurence, Zanichelli, Andrea, Caballero, Teresa, Longhurst, Hilary J., Perrin, Amandine, Andresen, Irmgard
Publicado 2017

Lanadelumab for the Prophylactic Treatment of Hereditary Angioedema with C1 Inhibitor Deficiency: A Review of Preclinical and Phase I Studies

por Busse, Paula J., Farkas, Henriette, Banerji, Aleena, Lumry, William R., Longhurst, Hilary J., Sexton, Daniel J., Riedl, Marc A.
Publicado 2018

Selective IgA Deficiency May Be an Underrecognized Risk Factor for Severe COVID-19

por Ameratunga, Rohan, Leung, Euphemia, Woon, See-Tarn, Lea, Edward, Allan, Caroline, Chan, Lydia, Steele, Richard, Lehnert, Klaus, Longhurst, Hilary
Publicado 2023